A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
A crowdfunding campaign has been set up to raise money needed for a legal battle to bring home Michael Sandford.
The 5p charge for a single-use carrier bag has had a clear impact on shoppers' behaviour, six months after being introduced.
Pothole-related damage might seem like a minor issue, but the RAC is called out for such issues by thousands of motorists each month.